POY_1170x120_8-12-19

Amy Klobuchar

Lawmakers push for action on drug costs

Lawmakers push for action on drug costs

WASHINGTON — Sens. John McCain (R., Ariz.) and Tammy Baldwin (D., Wis.) and Rep. Jan Schakowsky (D., Ill.) this week reintroduced the Fair Accountability and Innovative Research (FAIR) Drug Pricing Act, aimed at improving cost transparency for pharmaceutical price hikes. The FAIR Drug Pricing Act would require drug manufacturers to notify the Department of Health

NACDS warns Congress on danger of drug imports

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) sent a letter to all 100 U.S. senators last month ahead of a vote on an amendment that would allow Americans to purchase prescription drugs from Canada. In its letter, NACDS said that importation undermines the prescription drug safety net. “NACDS shares the goal

Senators question pricing of Mylan’s EpiPen

Senators question pricing of Mylan’s EpiPen

NEW YORK — Senate leaders have voiced concerns about a price surge for Mylan Inc.’s EpiPen, an epinephrine auto-injector for treating anaphylaxis, or potentially life-threatening allergic reactions. Sen. Chuck Grassley (R, Iowa), chairman of the Senate Judiciary Committee, and Sens. Susan Collins (R., Maine) and Claire McCaskill (D., Mo.), chairman and ranking member of the

WBA-Rite Aid deal likely to draw scrutiny from regulators

DEERFIELD, Ill. — Walgreens Boots Alliance may have to divest up to 400 of the Rite Aid stores it is acquiring to satisfy antitrust regulations, analysts said. WBA is not publicly speculating on how many units it will have to shutter, said chief executive officer Stefano Pessina. “We have analyzed things very carefully,” he said

Senators urge close scrutiny of WBA-Rite Aid deal

Senators urge close scrutiny of WBA-Rite Aid deal

WASHINGTON — Two U.S. senators with oversight for antitrust issues have called on federal regulators to take a close look at Walgreens Boots Alliance Inc.’s $17.2 billion deal to acquire Rite Aid Corp. Sen. Mike Lee (R., Utah), chairman of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and Sen. Amy Klobuchar